SURUNKALI OBSTRUKTIV O‘PKA KASALLIGIDA IMMUNOGENETIK MARKERLARNING PROGNOSTIK AHAMIYATI VA PERSONALIZATSIYALANGAN BAHOLASH

Authors

  • Qodirova Nilufar shokirovna Izlanuvchi: Buxoro viloyati Bolalar Ko`p tarmoqli tibbiyot Markazi vrach Laboranti
  • Satlikov.R.K Ilmiy Rahbar: Urganch Davlat Tibbiyot Instituti T.f.n, Dotsent

Keywords:

Kalit so‘zlar: SO‘OK, prognoz, immunogenetik marker, FEV1, eozinofiliya, zo‘rayish, SERPINA1, MMP9, IL-6, personalizatsiyalangan tibbiyot.

Abstract

Annotatsiya. Surunkali obstruktiv o‘pka kasalligining klinik kechishi bemorlar o‘rtasida sezilarli darajada farq qiladi. Ayrim bemorlarda o‘pka funksiyasi sekin pasaysa, boshqalarida tez-tez zo‘rayishlar, emfizema va nafas yetishmovchiligi rivojlanishi mumkin. Ushbu heterogenlikni tushuntirishda immunologik va genetik omillar muhim o‘rin tutadi. Immunogenetik markerlarni klinik va funksional parametrlar bilan birlashtirish SO‘OKning progressiyasi va zo‘rayish xavfini individual baholash uchun istiqbolli yo‘nalish hisoblanadi.

References

1.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD. 2026 Report.

2.Cazzola M., Bajpai J., Calzetta L. et al. GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care. Drugs. 2026.

3.Milne S., Sin D.D. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine. Clin Chest Med. 2020;41(3):383–394.

4.Clinical and molecular markers in COPD. Pulmonology.

5.McCloskey S.C., Jones S.E., Hind C.R.K. et al. The role of genetic susceptibility in chronic obstructive pulmonary disease.

6.Silverman E.K., Sandhaus R.A. Alpha1-antitrypsin deficiency. N Engl J Med.

Downloads

Published

2026-10-09

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.